genOway logo_Virtual booth_600x3142

About Us

 

genOway is a global biotechnology company dedicated to improve the predictability and reliability of preclinical data through the development and commercialization of unique, innovative, genetically modified models with high physiological relevancy.

With a growing catalog of humanized immune checkpoint mouse and cell line models, and reconstituted mice featuring a human immune system, genOway offers a broad set of tools to study mechanism of actions, efficacy, and safety of immunotherapies aiming to enhance translatability toward the clinic.

Founded in 1999, genOway serves clients in 380 academic institutions and 170 life sciences companies, including 17 of the top 20 pharma.

External Links

Team Members

Emma

Emma Reungoat

Business Developer

Kader

Kader Thiam

Senior Vice President Discovery – Preclinical Models & Services